ACM
RNAZ icon

ACT Capital Management’s TransCode Therapeutics RNAZ Stock Holding History

ACT Capital Management’s Portfolio RNAZ Stock Details RNAZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– -$8K – 69
2022
Q2 		– Hold
0
– -$144K – 78
2022
Q1 		– Hold
0
– -$127K – 59
2021
Q4 		– Hold
0
– -$150K – 79
2021
Q3 		– Hold
0
– – – 84